The BioFire FilmArray Respiratory Panel (RP) tests for a comprehensive set of 20 respiratory viral and bacterial pathogens in about one hour. The BioFire RP identifies the most common viral and bacterial pathogens that cause respiratory tract infections that present with nearly indistinguishable symptoms. The rapid and accurate identification of the causative agent helps determine how a healthcare provider chooses to treat a respiratory tract infection.
The BioFire FilmArray Gastrointestinal (GI) Panel tests for a comprehensive set of 22 gastrointestinal pathogens. The BioFire GI Panel tests stool specimens for common pathogens associated with gastroenteritis. Quickly identifying the correct pathogen can ensure appropriate treatment, improve patient management, and help detect infectious gastroenteritis, which can lead to severe illness or death.
The BioFire FilmArray Meningitis/Encephalitis (ME) Panel tests for a comprehensive set of 14 bacteria, viruses, and yeast. The BioFire ME Panel identifies the most common viral, bacterial, and yeast pathogens that cause infections in the central nervous system, which in some cases can be life threatening. The diagnosis of meningitis and encephalitis can allow faster decisions on appropriate therapy to be made to prevent complications.
This sophisticated type of scan provided by 57357’s Nuclear Medicine department relies on the injection of the body with isotopes or radioactive material to detect the cancer at the cellular level or earliest formation. Offering the latest technology, 57357’s PET/CT unit is presently equipped with two machines, which help reduce waiting time of patients.
The PET/ CT test relies on a radioactive material the isotopes which have a certain half-life. Hospital 57357 owns the cyclotron equipment, which produces the isotopes. Doing the test at 57357 is secured by the on-site constant production of isotopes.
Moreover, the Nuclear Medicine department has initiated a novel detection technique based on the usage of radioactive material F18-FET. An agent in PET imaging particularly effective in Brain Tumors. The 57357 cyclotron is presently the first unit in the Middle East and Africa to produce the radioactive positron F18-FET.
Another test is offered to prostate cancer patients utilizing a third kind of radioactive material, the F18-PSMA, also produced by 57357’s cyclotron.
The unit is offering women to take an advantageous package of the three tests at a cost that would almost equal the cost of one test if done separately. However the cost of each individual test is still less expensive than the market cost.